fostriecin and Liver-Neoplasms

fostriecin has been researched along with Liver-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for fostriecin and Liver-Neoplasms

ArticleYear
The causal relationship between white blood cell counts and hepatocellular carcinoma: a Mendelian randomization study.
    European journal of medical research, 2022, Dec-06, Volume: 27, Issue:1

    Most of hepatocellular carcinoma (HCC) arises on the background of chronic inflammation. The presence of infiltrating inflammatory cells is associated with tumour initiation, progression and clinical response to treatment. The influence of white blood cell (WBC) subtype counts on HCC progression remains unclear.. In this study, we performed a Mendelian randomization (MR) study with the validation of two datasets. The summary data for WBC counts were extracted from a recent large GWAS of individuals of European ancestry. The GWAS data related to HCC were obtained from the UK Biobank (UKB). Univariable and multivariable MR analyses were used to identify risk factors genetically associated with HCC risks.. In the discovery dataset, multivariable MR analysis revealed that sum basophil neutrophil counts had an independent causal effect on the occurrence of HCC, with the sum basophil neutrophil counts as follows: (OR = 0.437, P = 0.003, CI 0.252-0.757). Similarly, in the validation dataset, total basophil neutrophil counts were also been identified as an independent risk factor for HCC. The sum basophil neutrophil counts were as follows: (OR = 0.574, P = 0.021, CI 0.358-0.920).. In the European population, genetically predicted lower total basophil neutrophil counts might be an independent risk factor for HCC.

    Topics: Carcinoma, Hepatocellular; Humans; Leukocyte Count; Liver Neoplasms; Mendelian Randomization Analysis; Neutrophils; Polymorphism, Single Nucleotide

2022